Rochester, NY (PRWEB) June 09, 2014
A study found that Hispanic Americans had more damaging results from stroke (1). “Hispanics have a different prevalence of risk factors for stroke when compared with non-Hispanic whites. For instance, they have strokes at younger ages.” (See the StrokeAssociation.org, last updated on October 2012.) (2). In addition to diabetes, heavy alcohol use, and obesity (2), some studies also suggest that stroke is linked to viral infections. For example, “Infection with the VZV virus (a herpes virus) increases the risk of stroke, transient ischemic attack, and heart attack dramatically. “HZ (herpes zoster) is an independent risk factor for vascular disease… particularly for stroke.” (See Neurology, from January 21, 2014) (3). In addition, Hispanics have “an increased risk of stroke especially at younger ages, as well as a higher prevalence of infections caused by several persistent (viral) pathogens.” (See PLoS One, from 2013) (4).
polyDNA recommends that individuals who want to help their immune system target latent, viral infections take Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was shown to reduce viral symptoms in two post-marketing clinical studies that followed FDA guidelines. Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. The formula of each contains 5 natural ingredients. These are selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. That's 4 plant extracts and 1 trace element. Each ingredient of Gene-Eden-VIR and Novirin was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses. Gene-Eden-VIR and Novirin are the only natural antiviral products that were tested in clinical studies. These studies showed that the formula reduced viral symptoms.
“Evidence suggests that acute infection (e.g., respiratory tract and urinary tract) is indeed a generic trigger for acute stroke.” (See Medscape.com, from 2009) (5). Specifically, a review of the scientific literature found that “in recent decades, the clinical spectrum of VZV vasculopathy has expanded to include,” many other types of viral induced strokes (See Current Infectious Disease Reports, from June 2014) (6).
“Hispanic Americans are already at a high risk for stroke according to research. Studies clearly show that herpes viruses, such as VZV, increase the risk even further. We therefore recommend Gene-Eden-VIR or Novirn, natural antivirals that were proven to be safe and effective in two clinical studies that followed FDA guidelines.” – Mike Evans, polyDNA
Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients. The Novirin/Gene-Eden-VIR formula was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology.
Interested individuals can view the two published studies here http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.
Up to 70% of those studied reported a decrease in symptoms associated with a latent viral infection, and users of the Novirin and Gene-Eden-VIR formula experienced an increase in overall health (7).
Each ingredient of the Gene-Eden-VIR and Novirin formula was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses.
A second clinical study showed that the Novirin/Gene-Eden-VIR formula decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (8).
All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) Neurological, functional, and cognitive stroke outcomes in Mexican Americans. Published in April 2014.
(2) Stroke Among Hispanics. Updated in October 2012.
(3) Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Published on January 21, 2014.
(4) Antibody levels to persistent pathogens and incident stroke in Mexican Americans. Published on June 14, 2013.
(5) Stroke as a Complication of Medical Disease. Published in 2009.
(6) Update on varicella zoster virus vasculopathy. Published in June 2014.
(7) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
(8) Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Novirin, an antiviral natural remedy that helps the immune system kill latent viruses.